Ipswich Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Sell
3,575
-133
-4% -$63.8K 0.38% 57
2026
Q1
$1.82M Buy
3,708
+8
+0.2% +$4.34K 0.43% 56
2025
Q4
$2.14M Buy
3,700
+8
+0.2% +$4.52K 0.5% 48
2025
Q3
$1.79M Sell
3,692
-678
-16% -$316K 0.42% 56
2025
Q2
$1.77M Sell
4,370
-2,075
-32% -$868K 0.43% 57
2025
Q1
$3.21M Sell
6,445
-4
-0.1% -$2.17K 0.8% 34
2024
Q4
$3.35M Sell
6,449
-400
-6% -$220K 0.81% 35
2024
Q3
$4.24M Buy
6,849
+3
+0% +$1.78K 0.98% 32
2024
Q2
$3.79M Buy
6,846
+65
+1% +$37.2K 0.89% 35
2024
Q1
$3.94M Buy
6,781
+12
+0.2% +$6.73K 0.92% 34
2023
Q4
$3.59M Buy
6,769
+120
+2% +$58.1K 0.91% 36
2023
Q3
$3.37M Sell
6,649
-91
-1% -$48.5K 0.92% 34
2023
Q2
$3.52M Buy
6,740
+8
+0.1% +$4.32K 0.93% 33
2023
Q1
$3.88M Sell
6,732
-118
-2% -$66.5K 1.06% 30
2022
Q4
$3.77M Sell
6,850
-30
-0.4% -$15.9K 1.08% 32
2022
Q3
$3.49M Sell
6,880
-212
-3% -$119K 1.11% 27
2022
Q2
$3.85M Sell
7,092
-21
-0.3% -$11.6K 1.11% 28
2022
Q1
$4.2M Sell
7,113
-70
-1% -$40.2K 1.04% 29
2021
Q4
$4.79M Sell
7,183
-175
-2% -$109K 1.12% 24
2021
Q3
$4.2M Buy
7,358
+142
+2% +$77.9K 1.08% 26
2021
Q2
$3.64M Buy
7,216
+188
+3% +$88.7K 0.93% 35
2021
Q1
$3.21M Buy
7,028
+330
+5% +$158K 0.9% 38
2020
Q4
$3.12M Buy
6,698
+165
+3% +$77.4K 0.94% 38
2020
Q3
$2.88M Sell
6,533
-76
-1% -$31.4K 0.92% 37
2020
Q2
$2.4M Sell
6,609
-164
-2% -$55K 0.82% 41
2020
Q1
$1.92M Sell
6,773
-968
-13% -$305K 0.76% 46
2019
Q4
$2.52M Sell
7,741
-25
-0.3% -$7.58K 0.74% 46
2019
Q3
$2.26M Sell
7,766
-7
-0.1% -$2K 0.72% 47
2019
Q2
$2.28M Buy
7,773
+35
+0.5% +$9.64K 0.73% 44
2019
Q1
$2.12M Buy
7,738
+350
+5% +$87.1K 0.69% 45
2018
Q4
$1.65M Buy
7,388
+40
+0.5% +$9.38K 0.61% 50
2018
Q3
$1.79M Buy
+7,348
New +$1.69M 0.61% 55
2018
Q2
Sell
-7,932
Closed -$1.64M 144
2018
Q1
$1.64M Sell
7,932
-58
-0.7% -$12.2K 0.69% 44
2017
Q4
$1.52M Buy
7,990
+30
+0.4% +$5.75K 0.64% 47
2017
Q3
$1.51M Sell
7,960
-5
-0.1% -$906 0.68% 46
2017
Q2
$1.39M Sell
7,965
-1,320
-14% -$222K 0.65% 46
2017
Q1
$1.43M Buy
9,285
+30
+0.3% +$4.58K 0.62% 47
2016
Q4
$1.31M Buy
9,255
+865
+10% +$128K 0.59% 52
2016
Q3
$1.33M Buy
8,390
+875
+12% +$135K 0.65% 50
2016
Q2
$1.11M Buy
7,515
+6,520
+655% +$962K 0.55% 55
2016
Q1
$147K Buy
+995
New +$133K 0.07% 146

Other funds holding TMO

Ipswich Investment Management's TMO Position: Q2 2026 in Review

Ipswich Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 3.6% in Q2 2026, selling an estimated $63.8K and leaving 3,575 shares worth $1.79M. The position accounts for 0.38% of the portfolio, ranked #57.

Ipswich Investment Management first reported a position in TMO in Q1 2016 and has held it in 41 quarters since. The position peaked at $4.79M in Q4 2021. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ipswich Investment Management held 3,575 shares of Thermo Fisher Scientific worth $1.79M as of Q2 2026.
  • Ipswich Investment Management sold 133 Thermo Fisher Scientific shares in Q2 2026, an estimated $63.8K.
  • Thermo Fisher Scientific made up 0.38% of Ipswich Investment Management's portfolio in Q2 2026, its #57 holding.
  • Ipswich Investment Management first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 41 quarters since.
  • Ipswich Investment Management's Thermo Fisher Scientific position peaked at $4.79M in Q4 2021.
  • 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.